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Abstract 
Tuberculosis (TB) causes disease worldwide and multi-drug resistance is an 
increasing problem. Matrix metalloproteinases (MMPs), particularly the collagenase 
MMP-1, cause lung extracellular matrix destruction which drives disease 
transmission and morbidity. The role in such tissue damage of the stromelysin MMP-
10, a key activator of the collagenase MMP-1, was investigated in direct 
Mycobacterium tuberculosis (Mtb) infected macrophages and in conditioned medium 
from Mtb infected monocytes (CoMtb)-stimulated cells. Mtb infection increased 
MMP-10 secretion from primary human macrophages 29-fold, while CoMtb 
increased secretion by 4.5-fold from pulmonary epithelial cells and 10.5-fold from 
fibroblasts. Inhibition of MMP-10 activity decreased collagen breakdown. In two 
independent cohorts of TB patients from different continents, MMP-10 was increased 
in both induced sputum and bronchoalveolar lavage fluid compared to controls and 
patients with other respiratory diseases (both p<0.05). Mtb drove 3.5-fold greater 
MMP-10 secretion from human macrophages than the vaccine strain BCG (p<0.001), 
whereas both mycobacteria upregulated TNFα secretion equally. Using overlapping 
short linear peptides covering the sequence of ESAT-6, a virulence factor secreted 
by Mtb but not BCG, we found  that stimulation of human macrophages with a single 
specific 15 amino acid peptide sequence drove 3-fold greater MMP-10 secretion 
than any other peptide (p<0.001). Mtb-driven MMP-10 secretion was inhibited in a 
dose-dependent manner by p38 and ERK MAPK blockade (p<0.001 and p<0.01 
respectively), but was not affected by inhibition of NF-ĸB.   
In summary, Mtb activates inflammatory and stromal cells to secrete MMP-10 and 
this is partly driven by the virulence factor ESAT-6, implicating it in TB-associated 
tissue destruction. 
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Introduction 
There were 9.6 million cases and 1.5 million deaths attributed worldwide to 
tuberculosis (TB) in 2014,  and rising drug resistance is of great concern  (1). To 
develop new therapeutic approaches, it is critical to understand underlying 
mechanisms of disease. In pulmonary TB, extracellular matrix (ECM) breakdown 
causes cavitation and facilitates Mtb transmission (2), drug resistance (3) and also 
increases morbidity and mortality (4). Matrix metalloproteinases (MMPs) are zinc 
dependent proteolytic enzymes, which are involved in pulmonary ECM turnover and 
have diverse immunological roles such as chemokine processing (5). These 
enzymes may be secreted by leukocytes and stromal cells during Mtb-infection (6, 
7). Triple helical collagens (types I – III) are the primary structural fibrils of the lung, 
and MMP-1 and MMP-8 are the predominant secreted collagenases in TB (8, 9). 
Accumulating evidence from murine and human studies implicates the interstitial 
collagenase or MMP-1 as a key effector in tissue destruction and cavity formation in 
pulmonary TB (10, 11).  
 
MMP-10, also known as Stromelysin-2, may promote breakdown of collagen within 
the ECM, by regulating MMP-1 collagenase activity at both the gene expression level 
and via zymogen activation (12-14). MMP-10 has also been shown to cleave 
fibronectin, laminin and type IV collagen in in vitro studies (15). A pathological role 
for MMP-10 in other pulmonary diseases involving ECM degradation has been 
reported, including lung malignancy (16) and emphysema (17). MMP-10 activation of 
MMP-1 is of importance in disease models of angiogenesis (14), and MMP-10 gene 
expression has been shown to be induced by some bacterial infections (18). Besides 
ECM breakdown, MMPs may have additional functional roles in the immune 
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response to infections by modulating cytokine processing, defensin activation (5), or 
leukocyte influx (19). Recently, a novel role for MMP-10 on macrophage polarization 
was identified in Pseudomonas aeruginosa infection (20). However, MMP-10 has not 
been systematically investigated in TB. 
 
The region of difference 1 (RD1) is a key determinant of mycobacterial pathogenicity 
and is absent from all avirulent strains of M. bovis BCG and M. microti. Deletion of 
RD1 from Mtb results in significant strain attenuation (21). The early secretory 
antigenic target-6 (ESAT-6) and the culture filtrate protein-10 (CFP-10) are encoded 
by RD1 genes Rv3874 and Rv3875, are secreted by Mtb and are highly 
immunogenic. They have pleiotropic effects on both innate and adaptive immune 
responses. For example, ESAT-6 induces macrophage apoptosis and interacts with 
TLR2 to decrease IL-12 secretion, which can favour a Th2 phenotype (22). ESAT-6 
and ESAT-6:CFP-10 complexes may cause pneumocyte cell lysis facilitating Mtb 
dissemination in the lung (23).  ESAT-6 also regulates migratory gradients via MMP-
9 (24), but the effect of ESAT-6 on MMP-derived tissue destruction has not been 
investigated. 
 
In this study, we investigated MMP-10 secretion from human macrophages and 
stromal cells in TB. We measured MMP-10 concentrations in patients, studying 
sputum and bronchoalveolar lavage fluid (BALF) from two geographically distinct 
groups, and analysed the mechanisms regulating MMP-10 gene expression and 
secretion, identifying a novel role for ESAT-6 in driving MMP secretion.   
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Materials and Methods 
Clinical TB studies 
Studies were approved by the University of Cape Town (HREC Refs 509/2009 and 
516/2011) and Nalanda University Hospitals Research Ethics Committees (REC 
SS/0810/TB). Informed consent was obtained in all cases.  In Ubuntu clinic, Cape 
Town, TB and control patient recruitment, recording of data, sputum induction and 
processing was performed as described (25). In the Nalanda University Hospital, 
Patna, TB and respiratory symptomatic patient recruitment and BALF collection and 
processing were performed as described (26). 
 
 
Reagents  
SB203580, PD98059 and SC-514 (Millipore, Beeston, UK) were used to block 
activity of p38 mitogen activated protein kinase (MAPK), extracellular signal related 
kinase (ERK) and nuclear factor-κB (NF-ĸB) respectively.   
Anti-human MMP-10 (Abcam, Cambridge, UK) and HRP-conjugated anti-rabbit IgG 
(Cell Signaling, Boston, USA) antibodies were used for western blot. MMP10 
neutralizing antibody and IgG2B isotype control antibody (R&D Systems, Abingdon, 
UK) were used for functional assays. 
Lipoarabinomannan (LAM, Colorado State University, USA) and peptides covering 
the entire ESAT-6 sequence (Pepceuticals, Enderby, UK) were used to stimulate 
macrophages. Peptides sequences are shown in Table 1. Peptide purity was>90% 
by mass spectrometry. 
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Cell culture 
Human monocytes were matured over 5 days in RPMI with 100ng/ml M-CSF (R&D 
Systems), 2mM glutamine, 10μg/ml ampicillin and 10% heat inactivated FBS. 
Macrophages in serum-free media were infected with Mtb H37Rv or BCG at 
multiplicity of infection (MOI) 1, which were cultured in Middlebrook 7H9 medium (BD 
Biosciences, Oxford, UK) and used at mid-log growth.   
Normal human bronchial epithelial (NHBE) cells (Lonza, Slough, UK) were cultured 
according to suppliers’ instructions. MRC-5 lung fibroblasts were cultured in MEM 
with 2mM glutamine, 10μg/ml ampicillin, 1% sodium pyruvate, non-essential amino 
acids and 10% FBS. Experiments commenced at 80% confluence.  
 
 
Conditioned Medium from Mtb infected Monocytes (CoMtb)  
CoMtb was prepared as previously described (27). Briefly, monocytes were infected 
with Mtb H37Rv at a MOI 1, incubated for 24h and supernatants sterile filtered . 
Medium from uninfected monocytes was termed CoMCont.  
 
 
MMP-10, TNFα ELISA and Luminex assays 
ELISA Duoset kits (R&D Systems) were used to measure MMP-10 and TNFα 
concentrations in cell supernatants. Lower detection limits were 31.2pg/ml and 
15.6pg/ml respectively. MMP-10 Fluorokine beads (R&D Systems) were used to 
measure concentrations of MMP-10 in induced sputum and BALF samples on the 
Luminex 200 platform (Bio-Rad, Hertfordshire, UK). Lower detection limit was 
3.2pg/ml. Assays were performed as per manufacturer’s instructions. 
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Real-Time Polymerase Chain Reaction (RT-PCR) 
Total RNA was extracted using the Purelink RNA Mini Kit (Life Technologies) and 
reverse transcribed with the Quantitec Reverse Transcription Kit (Qiagen, 
Manchester, UK). RT-PCR was performed on a Stratagene Mx3000Pro using MMP-
10 and β-actin primers and probes (Applied Biosystems, Warrington, UK). Analysis 
was performed using ΔΔCt method.  
 
 
Collagenase activity 
MMP-1 collagenolytic activity was measured using EnzChek DQ type I collagen 
assay (Life Technologies) performed as per manufacturer’s instructions. DQ collagen 
coated slides were used for confocal microscopy. 
 
 
Statistical analysis 
Statistical analysis was performed using GraphPad Prism. Mann-Whitney U, 
Student’s unpaired t-test or one-way analysis of variance with Tukey’s post hoc 
analysis were used as appropriate. p<0.05 was considered significant.   
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Results 
Mtb Infection drives MMP-10 secretion from human macrophages, respiratory 
epithelial cells and fibroblasts 
First, MMP-10 secretion from Mtb-infected macrophages was investigated. Mtb 
caused a dose dependent upregulation in MMP-10 secretion, causing a 20.2-fold 
increase (370±331.6pg/ml to 7461.7±2073.7pg/ml) increase at a MOI of 0.5 and 29-
fold (10719.3±1713.2pg/ml) at a MOI of 1 compared to uninfected macrophages 
(both p<0.001).  Low dose infection at MOI of 0.1 did not upregulate MMP-10 (Fig. 
1A). Kinetic studies showed a 5.1-fold upregulation of MMP-10 secretion from Mtb-
infected macrophages at 48 hours (p<0.01) increasing to 31.5-fold at 72 hours 
(p<0.001; Fig. 1B). Western blotting confirmed that Mtb stimulation drives MMP-10 
secretion from macrophages at 72 hours (Fig. 1C).  Increased secretion was 
secondary to increased gene expression, as Mtb increased MMP-10 mRNA 
accumulation by 182-fold compared to uninfected macrophages at 24 hours (p< 
0.0001; Fig.1D).  
 
Next, we investigated MMP-10 secretion from CoMtb-simulated pulmonary epithelial 
cells and fibroblasts to investigate the effects of monocyte-dependent intercellular 
networks. CoMtb-stimulation increased MMP-10 secretion by 4.5-fold (from 
2525±208.5pg/ml to 11250±886.1pg/ml; p<0.0001) from epithelial cells (Fig. 1E) and 
10.5-fold from fibroblasts (from 641.7±152.9pg/ml to 6715.7±391.9pg/ml; p<0.0001; 
Fig. 1F) compared to unstimulated cells.  
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To confirm that MMP-10 was functionally active and affected MMP-1 collagenolytic 
activity, 15μg/ml MMP-10 neutralizing antibody was used to block MMP-10 activity.  
Collagenolytic activity was analysed using DQ type I collagen, which fluoresces in 
areas of collagen degradation.  A significant increase in collagen breakdown was 
observed in macrophages infected with Mtb by confocal microscopy, compared with 
uninfected controls. Inhibition of MMP-10 activity led to inhibition of DQ collagen 
degradation by Mtb infected macrophages (Fig. 2A).  Similarly, in CoMtb-stimulated 
NHBE cells, addition of 15μg/ml MMP-10 neutralizing antibody significantly 
decreased collagen breakdown (p<0.0001; Fig. 2B).  
 
 
MMP-10 is increased at the site of infection in patients with pulmonary TB  
To investigate the relevance of MMP-10 in clinical disease, we measured MMP-10 
levels in the respiratory secretions of two separate patient cohorts. We studied 
induced sputum of patients with TB (mixed HIV serostatus) and non-TB controls from 
South Africa, and BALF of HIV-uninfected TB patients compared to patients with 
non-tuberculous respiratory disease from India.  MMP-10 concentrations were 
increased in patients with TB compared to controls groups for both these cohorts 
(Fig. 3; p<0.05). In the induced sputum study of South African patients, MMP-10 
concentrations were 5067pg/ml (1440–19077pg/ml) in TB patients compared to 
2648pg/ml (797–5914pg/ml) in controls. In BALF, MMP-10 concentrations were 
6531pg/ml (637-11929pg/ml) in TB patients compared to 783pg/ml (76-5473pg/ml) in 
respiratory symptomatic controls. MMP-10 mRNA accumulation was also increased 
by 60% in induced sputum of TB patients compared with controls, normalised to β-
actin (Fig. 3B; p<0.05). Therefore, these findings show that MMP-10 is present at the 
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site of disease in pulmonary TB and that concentrations are higher in TB compared 
to other respiratory diseases.  
 
 
MMP-10 Expression in Human macrophages is driven by virulent Mtb but not 
by lipoarabinomannan or the Vaccine Strain BCG  
Next, we investigated whether MMP-10 secretion was driven specifically by virulent 
Mtb or was a non-specific response to infection. LAM is a mycobacterial cell wall 
component and principally a TLR2 agonist known to be important in inflammatory 
responses to Mtb (28). Stimulation of macrophages with 10μg/ml LAM resulted in 
MMP-10 secretion which was 5% of that observed after stimulation with live Mtb (Fig. 
4A).  In contrast, TNF secretion from macrophages in response to LAM and direct 
Mtb infection were similar (Fig. 4B). LAM stimulated MMP-1 secretion which was 
30% of that driven by direct Mtb infection (data not shown). 
 
Tissue destruction is not usually a feature of pulmonary infection with the vaccine 
strain M. bovis BCG (29).  MMP-10 concentrations following macrophage infection 
with BCG were 586.3±96.7pg/ml compared to 2047.7±347pg/ml from Mtb-infected 
macrophages at 72 hours (Fig. 4C, p<0.001). Mtb infection of macrophages 
upregulated MMP-10 gene expression 4–fold more than BCG infection at 24 hours 
(Fig. 4D, p< 0.001), demonstrating that the divergent effects of BCG and Mtb on 
MMP-10 secretion are transcriptionally regulated. In contrast, Mtb and BCG 
stimulated similar TNFα secretion from macrophages at 72 hours (Fig. 4E). Colony 
counting confirmed equal infectious doses of Mtb and BCG were used in these 
experiments (data not shown).  
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 MMP-10 secretion is dependent on a specific 15 amino acid peptide sequence 
in ESAT-6 of Mtb 
Since BCG did not drive MMP-10 secretion and lacks the RD1 region in its genome 
(30), we investigated ESAT- 6, a protein encoded by the RD1 region which is 
implicated in Mtb virulence (31) and modulation of the host immune response (32, 
33). Macrophages were stimulated with a series of short linear peptide sequences 
from ESAT-6 (Table 1). Stimulation of macrophages with the total pool of all ESAT-6 
peptides at a concentration of 10μg/ml caused a 17.6-fold increase in MMP-10 
secretion (from 7.8±7.9pg/ml to 137.2±56.5pg/ml), while 1μg/ml ESAT-6 peptides 
increased MMP-10 by 4.7-fold (36.3±25.9pg/ml) compared with unstimulated 
macrophages at 72 hours (Fig. 5A, p<0.001). Next, overlapping pools containing 3-4 
peptides at a total concentration of 10μg/ml, defined by the matrix shown in Fig. 5B, 
were used to stimulate macrophages. Pools 1 and 8 were the only pools that caused 
significantly higher MMP-10 secretion at 72 hours than unstimulated macrophages, 
with a 5.2-fold and 3.9-fold upregulation respectively (Fig. 5C p<0.001 and p<0.01).  
The single peptide common to both these pools is ESAT-6 peptide 4, which has the 
sequence SAIQGNVTSIHSLLD (Table 1). Stimulation of macrophages with 10μg/ml 
ESAT-6 peptide 4 alone drove a 3-fold increase in MMP-10 secretion of 
66.7±11.7pg/ml compared to compared to the randomly selected ESAT-6 peptide 13 
(present in non-stimulatory peptide matrix pools 3 and 7) and an 4-fold increase in 
MMP-10 when compared to control, unstimulated macrophages at 72 hours (Fig 5D 
p<0.001), confirming peptide 4 was the dominant regulator of MMP-10.  
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MMP-10 Secretion from Mtb-stimulated macrophages is MAPK-dependent but 
NF-B independent   
Next, we investigated the role of key signalling pathways in control of Mtb-driven 
MMP-10 secretion. p38 MAPK inhibition caused a significant dose-dependent 
decrease in Mtb-driven MMP-10 secretion from macrophages at 72 hours (Fig. 6A). 
ERK MAPK inhibition caused a less marked but significant decrease in MMP-10 
secretion with 10μM PD98059 (Fig. 6B, p<0.01).  Similarly, blockade of both the p38 
and ERK MAP kinases inhibited MMP-10 gene expression (Fig. 6C, p<0.01). No 
significant cell death was observed with the concentrations of inhibitors used. 
 
NF-ĸB regulates gene expression of diverse MMPs including collagenases in TB (34, 
35).  MMP-10 does not have a consensus NF-ĸB binding site in its promoter 
although non-canonical binding was shown to the  promoter of the related 
stromelysin MMP-3 (36). NF-ĸB inhibition by the IKK-2 inhibitor SC-514 did not alter 
Mtb-driven MDM MMP-10 secretion (Fig. 6D). As a control, we confirmed that 10μM 
SC-514 reduced Mtb driven MMP-1 secretion by 51% (Fig. 6E), demonstrating that 
MMP-10 regulation is NF-κB independent.  
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Discussion 
 
The stromelysin MMP-10 regulates activity of the collagenase MMP-1, which plays a 
central role in TB pathogenesis (8), but has not previously been investigated in TB.  
In the present study, we showed that Mtb infection drives macrophage MMP-10 gene 
expression and secretion and investigated its regulation.  MMP-10 secretion was 
also increased by CoMtb stimulation of pulmonary epithelial cells and fibroblasts, 
which emphasizes a key role for monocyte-dependent networks in stimulating 
stromal cells, thereby amplifying the matrix-degrading response. Furthermore, MMP-
10 may be an important driver of type I collagen breakdown via its regulation of 
MMP-1 activity, since we demonstrated that inhibition of MMP-10 decreases 
collagen breakdown with Mtb-stimulation. Our data is consistent with other studies 
on the role of MMP-10 on pro-collagenase activation (13, 14), although in vivo 
studies that address these findings are still limited, possibly due to experimental 
challenges in providing in vivo correlates. 
Networking effects are similarly important in driving MMP-1 expression in TB (27, 35, 
37).  ESAT-6, a secreted virulence factor not expressed by the attenuated vaccine 
strain M. bovis BCG, upregulated MMP-10 secretion, implicating this pathway in 
mycobacterial pathology. Furthermore, increased MMP-10 expression has been 
shown to drive macrophage polarization towards an M2-like phenotype (20), an 
alternative-activated form of macrophage that is be present within TB granulomas 
and associated with Mtb persistence (38). 
In clinical studies, increased MMP-10 concentrations were detected in the respiratory 
secretions of patients with pulmonary TB relative to non-TB controls, and compared 
to patients with non-tuberculous pulmonary diseases.  These data were consistent 
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between two populations from different continents. To understand tissue destruction 
in human TB, it is important to study TB patients since most animal models do not 
accurately mimic the cavitatory disease seen in man (39). Our data are consistent 
with the observation that MMP-10 gene expression was 14-fold higher in human TB 
granulomas compared to normal lung tissue on microarray analysis (40).  Our finding 
of increased levels of the MMP-10 by Luminex bead array in induced sputum and 
BALF of TB patients shows that such increased gene expression translates to 
secreted protein which may augment pathology in clinical disease.  Furthermore, the 
finding in the Indian cohort of patients that MMP-10 is increased in the BALF of TB 
patients compared to patients with other respiratory diseases indicates that there is 
some specificity in the increased MMP-10 concentrations in TB.  MMP-10 activity 
has been implicated in other destructive pulmonary pathology, such as COPD (41), 
and was associated with disease severity and prognosis in patients with idiopathic 
pulmonary fibrosis (42).  Although our study implicated MMP-10 in the protease 
network upregulated in TB, as MMP-10 was increased in respiratory secretions of TB 
patients and at gene expression level, we did not precisely define the cellular source. 
However, it is most likely due to an MMP-amplification network involving multiple cell 
types within the granuloma including macrophages, respiratory epithelial cells and 
fibroblasts.  
 
Tissue destruction and cavitation are a feature of pulmonary TB, whereas 
administration of vaccine BCG does not cause lung pathology in immunocompetent 
individuals (29). Mtb and BCG caused similar upregulation in TNFα secretion, 
showing that BCG causes a pro-inflammatory reaction, but did not upregulate MMP-
10. This finding suggested that specific factors present in Mtb but not BCG were 
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responsible for driving MMP-10 expression. RD1 is a region absent in the genome of 
all BCG  strains and avirulent mycobacteria, but present in virulent M. bovis and Mtb 
(30). Mice infected with a RD-augmented BCG in showed an increased bacterial 
growth rate and inflammatory cell infiltration  with granuloma formation, confirming its 
role in pathogenesis, but an emerging paradigm is that RD1 has multiple effects to 
cause pathology  (24, 31). We employed an overlapping pool of peptides spanning 
the entire ESAT-6 sequence to identify a single linear 15aa sequence which alone 
was sufficient to drive MMP-10 secretion from macrophages. Thus, ESAT-6-
dependent MMP-10 secretion is an additional pathological mechanism through which 
this protein promotes Mtb virulence. This peptide, along with other ESAT-6 
fragments, has been shown previously to induce specific IFN-γ -secreting T cells 
(43). Therefore, it is possible that in macrophages this peptide may act as a 
pathogen associated molecular pattern (PAMP) to activate pattern recognition 
receptors (44, 45). 
 
There are multiple signalling pathways involved in the innate immune response to 
Mtb. TLR activation by Mtb infection drives activation of signalling molecules MyD88, 
p38, ERK, PI3K and NF-κB pathways (46, 47). These pathways have been shown to 
regulate diverse MMPs in Mtb infection and other diseases, but their importance in 
controlling MMP-10 expression has not been assessed. MMP-10 secretion from Mtb 
infected macrophages was regulated by both p38 and ERK MAP kinase signalling. 
ESAT-6, which we showed activated MMP-10 secretion, is also known to increase 
p38 and ERK MAPK phosphorylation in macrophages. MAP kinases often activate 
inflammatory mediators in a NF-kB dependent manner (37, 48). Both Mtb and LAM 
stimulation activated TLR2 leading to similar TNF-α induction via MAP/ NF-kB 
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signalling. However, our data shows that MMP-10 upregulation appears independent 
of NF-kB. It is possible that the independence of MMP-10 expression from the NF-ĸB 
/TLR2 signalling pathway may be part of a regulatory network to limit inflammation, 
as less MMP-10 at the site of disease may prevent excessive tissue destruction. 
Activator Protein 1 (AP-1) and Signal Transducer and Activator of Transcription 
(STAT), both of which have consensus binding sites in the MMP-10 promoter (49), 
may be more important factors and are known to regulate ERK-dependent MMP-10 
expression in cardiomyocytes (50).  
 
In summary, MMP-10 is upregulated by macrophage Mtb infection and by TB-
dependent networks acting on respiratory epithelial cells and fibroblasts. MMP-10 is 
elevated in induced sputum and BALF of patients with TB. MMP-10 expression 
during Mtb infection is specifically driven by a central peptide sequence within ESAT-
6, which is absent in BCG, causing ERK and p38 MAPK-dependent expression of 
MMP-10.  In pulmonary TB, MMP-10 may have a key role in promoting tissue 
destruction and cavitation, acting at the apex of a proteolytic cascade resulting in 
matrix degradation.  
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Tables 
Table 1- ESAT-6 overlapping peptide sequences. 
 
 
 
 
 
 
 
 
 
 
 
  
Peptide number Sequence 
1 MTEQQWNFAGIEAAA 
2 WNFAGIEAAASAIQG 
3 IEAAASAIQGNVTSI 
4 SAIQGNVTSIHSLLD 
5 NVTSIHSLLDEGKQS 
6 HSLLDEGKQSLTKLA 
7 EGKQSLTKLAAAWGG 
8 LTKLAAAWGGSGSEA 
9 AAWGGSGSEAYQGVQ 
10 SGSEAYQGVQQKWDA 
11 YQGVQQKWDATATEL 
12 QKWDATATELNNALQ 
13 TATELNNALQNLART 
14 NNALQNLARTISEAG 
15 NLARTISEAGQAMAS 
16 ISEAGQAMASTEGNV 
17 QAMASTEGNVTGMFA 
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Figure Legends 
Figure 1- Mtb Infection drives MMP-10 secretion from macrophages, 
respiratory epithelial cells and fibroblasts. 
A MMP-10 secretion from macrophages infected with increasing MOI of Mtb. B 
Kinetics of MMP-10 secretion from Mtb infected macrophages (MOI 1). C Western 
blot on cell supernatants were performed to analyse secreted MMP-10 by 
macrophages after 72h of Mtb-infection. MMP-10 corresponds to a band of 54kDa. D 
MMP-10 gene expression in Mtb infected macrophages. MMP-10 transcript 
abundance was measured by RT-PCR and was normalized to β-actin. Copy 
numbers were calculated from standard curves with known concentrations of MMP-
10 and β-actin. E MMP-10 secretion from CoMtb (1:5 dilution) stimulated pulmonary 
epithelial cells at 72h. F MMP-10 secretion from CoMtb (1:10 dilution) stimulated 
pulmonary fibroblasts at 72h. Data corresponds to mean±SD and are representative 
of at least 2 independent experiments performed in triplicate.**p<0.01, ***p<0.001, 
****p<0.0001. 
 
Figure 2- Mtb-driven MMP-10 is required for MMP-1 collagenolytic activity in 
macrophages and respiratory epithelial cells.  
A Confocal microscopy figures of collagen breakdown in control macrophages, 
infected with Mtb (MOI 1) and where MMP-10 activity was inhibited by 15μg/ml 
neutralizing antibody. 15μg/ml of an IgG2B isotype was used as control. Nucleic 
acids were stained with DAPI (blue), while DQ type I collagen breakdown is shown 
by release of FITC fluorescence (green). Overlay of DAPI, FITC and bright field is 
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also shown in the last row of panels. Scale bar: 50μm. B Supernatants of NHBE cells 
stimulated for 72h with CoMCont, CoMtb and where MMP-10 activity was inhibited 
by 15μg/ml neutralizing antibody where used on a DQ type I collagen assay. 15μg/ml 
of an IgG2B isotype was used as control. Increase in fluorescence corresponds to 
increase in DQ collagen breakdown. Data corresponds to mean±SD and are 
representative of at least 2 independent experiments performed in triplicate. 
****p<0.0001; ns- not significant. 
 
Figure 3- MMP-10 is elevated in pulmonary TB in two independent cohorts of 
distinct ethnicity. 
A Induced sputum samples were collected prospectively from patients with active 
pulmonary TB (n=21) and non-TB controls (n=21) in Cape Town, South Africa.  B 
BALF samples were collected prospectively from patients with active pulmonary TB 
(n=14) and patients with other non-tuberculous pulmonary diseases (n=17) in Patna, 
India. MMP-10 concentrations were measured by Luminex, and in each cohort MMP-
10 was elevated in patients with TB.  C Induced sputum samples were collected 
prospectively from HIV-negative patients with active pulmonary TB (n=11) and 
healthy controls (n=17) in Cape Town, for RNA extraction. MMP-10 mRNA 
accumulation was analysed by reverse transcription RT-PCR using β-actin mRNA as 
control.  Statistical analysis was performed using a Mann-Whitney U test (*p<0.05).  
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Figure 4- MMP-10 secretion in human macrophages is driven by Mtb but not by 
mycobacterial LAM or vaccine BCG strain.  
MMP-10 and TNFα secretion from macrophages in response to Mtb infection (MOI 
1) or stimulation with lipoarabinomannan (LAM; 10µg/ml). A MMP-10 secretion from 
macrophages at 72h post-stimulation with LAM or Mtb. B TNFα secretion from 
macrophages at 72h post-stimulation with LAM or Mtb. C MMP-10 secretion at 72h 
from Mtb (MOI 1) infected macrophages compared to BCG-infected macrophages 
(MOI 1). D MMP-10 gene expression at 24h from Mtb infected macrophages 
compared to BCG infected macrophages (normalised to β-actin). E. TNFα secretion 
from Mtb infected macrophages and BCG infected macrophages at 72h. Data 
corresponds to mean±SD and are representative of 3 independent experiments 
performed in triplicate. **p<0.01, ***p <0.001.  
 
Figure 5- A 15 amino acid peptide sequence of ESAT-6 drives MMP-10 
secretion from human macrophages. 
A MMP-10 secretion from macrophages stimulated with complete pool of 17 
overlapping ESAT-6 peptides spanning the entire protein sequence (see Table 1). B 
Matrix indicating peptides present in pools 1 to 9 pools 1-9 containing all peptides 
(P1-P17). C MMP-10 secretion from macrophages stimulated with the ESAT-6 
peptide pools from the matrix. D MMP-10 secretion from macrophages stimulated 
with ESAT-6 peptide 4 or ESAT-6 peptide 13 individually. Data corresponds to 
mean±SD and are representative of 3 independent experiments performed in 
triplicate.**p<0.01, ***p<0.001. 
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Figure 6- MMP-10 expression in Mtb-infected human macrophages is p38 and 
ERK MAPK dependent but NF-B independent.  
A, B MMP-10 secretion at 72h post- Mtb infection of human macrophages treated 
with chemical inhibitors of p38 (A) and ERK MAPK (B). macrophages were pre-
incubated with the p38 MAPK inhibitor SB203580 (SB) or the ERK MAPK inhibitor 
PD98059 (PD) at 1µM or 10µM for 2h prior to Mtb infection (MOI 1).  C MMP-10 
gene expression normalized to β-actin in Mtb infected macrophages SB (p38) or PD 
(ERK) chemical inhibitors. D, E MMP-10 (D) and MMP-1 (E) secretion from Mtb 
infected human macrophages with chemical inhibition of NF-ĸB signalling. 
macrophages were pre-incubated with SC-514 at 1µM or 10µM for 2h prior to Mtb 
infection.  Data corresponds to mean±SD and are representative of 3 independent 
experiments performed in triplicate. *p<0.05, **p<0.01, ***p<0.001. 
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Supplementary Material and Methods  
Western blotting  
Cell supernatants in loading buffer were run on NuPAGE 4-12% Bis-Tris gels (Life 
Technologies, Paisley, UK). Proteins were electro-transferred to nitro-cellulose membranes, 
which were blocked and incubated with rabbit anti-human MMP-10 (Abcam, Cambridge, 
UK) and HRP-conjugated goat anti-rabbit IgG (Cell Signalling, Boston, USA) antibodies, 
placed in chemiluminescent substrate and exposed to chemiluminescence film (ECL, GE 
Healthcare, Little Chalfont, UK). 
 
Confocal microscopy  
4-well glass slides were pre-coated with DQ type I collagen (Life Technologies). 
Macrophages were seeded and infected with Mtb (MOI= 1). MMP-10 activity was blocked 
using mouse anti-human MMP-10 neutralizing antibody (R&D systems). Mouse IgG2B 
antibody (R&D systems) was used as a control. 
Slides were fixed with 4% paraformaldehyde and DAPI was used as nuclear counterstain. 
Slides were scanned using a 40x oil immersion objective and to avoid bleed-through effects, 
each dye was scanned independently in a Leica TCS SP5 confocal microscope equipped with 
405nm diode laser, 488nm argon laser, 543nm and 633nm HeNe lasers and using the Leica 
Application Suite 2.6.2 software (Milton Keynes, UK). Images were edited using ImageJ 
software v1.46r (NIH, Maryland, USA). 
 
RNA extraction and Real-Time Polymerase Chain Reaction (RT-PCR) from induced 
sputum 
Sputum induction using nebulised 5% saline has previously described. 1ml of RNA later 
(Qiagen) was added on site to the samples which would be processed for RNA extraction. 
Mucolysis was performed by adding an equal volume of 0.1% Dithiothreitol (Sigma-Aldrich) 
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and agitating gently at room temperature for 20 min. The mucoid layer was filtered through 
100μm pore size strainer and centrifuged at 500g for 10 min. The cell pellet was aspirated 
and 1.5ml of cold TRI reagent added before vortexing. Total RNA was extracted using the 
Purelink RNA Mini Kit (Life Technologies) and reverse transcription RT-PCR was 
performed using 15ng RNA and the OneStep RT-PCR Kit (Qiagen), on a Stratagene 
Mx3000Pro using MMP-10 and β-actin primers and probes (Applied Biosystems, 
Warrington, UK).  Analysis was performed using the Pfaffl comparative Ct method, applying 
the equation: Ratio (MMP-10/ β-actin mRNA)= EMMP10
ΔCt(calibrator-sample)
/E β-actin
ΔCt (calibrator-
sample)
; E is the real-time PCR efficiency of one cycle in the exponential phase, calculated 
according to the equation: E= 10
[–1/slope]
. Samples without Ct for MMP-10 after 43 cycles but 
with Ct for the reference gene were considered negative. 
